|
Real-time Estimate
Cboe BZX
23:18:25 01/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 13.83 USD | +1.54% |
|
+4.15% | -20.44% |
| Market Cap | 8.02B 10.87B 9.36B 8.78B 15.06B 1,034B 15.17B 104B 40.5B 524B 40.8B 39.91B 1,736B | P/E 2026 * |
-11.6x | P/E 2027 * | -11.6x |
|---|---|---|---|---|---|
| Enterprise Value | 7.55B 10.23B 8.81B 8.27B 14.19B 974B 14.29B 98.02B 38.14B 494B 38.42B 37.58B 1,635B | EV / Sales 2026 * |
2,580x | EV / Sales 2027 * | 187x |
| Free-Float |
19.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Summit Therapeutics Inc.
| 1 day | +1.47% | ||
| 1 week | +4.15% | ||
| Current month | +2.17% | ||
| 1 month | +6.67% | ||
| 3 months | -11.43% | ||
| 6 months | -14.05% | ||
| Current year | -20.44% |
| 1 week | 13.37 |  | 15.1 |
| 1 month | 12.07 | | 15.75 |
| Current year | 12.07 | | 29.23 |
| 1 year | 12.07 | | 29.23 |
| 3 years | 1.52 | | 36.91 |
| 5 years | 0.66 | | 36.91 |
| 10 years | 0.66 | | 36.91 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 55 | 25/07/2022 |
Robert Duggan
CEO | Chief Executive Officer | 81 | 01/04/2020 |
| Director of Finance/CFO | 48 | 02/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Duggan
CHM | Chairman | 81 | 01/02/2020 |
| Director/Board Member | 48 | 01/12/2019 | |
Mahkam Zanganeh
BRD | Director/Board Member | 55 | 11/11/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/6/26 | Buy | Chief Executive Officer | 100,000 | 0.0129% | ||
| 4/6/26 | Buy | Chief Executive Officer | 100,000 | 0.0129% | ||
| 4/6/26 | Buy | Chief Financial Officer | 50,000 | 0.0064% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.54% | +4.15% | -41.63% | +753.68% | 10.87B | |
| -0.25% | -0.92% | +49.47% | +89.45% | 68.13B | |
| +1.26% | +0.84% | +46.35% | +85.40% | 63.6B | |
| +1.31% | +1.81% | +49.04% | +12.07% | 25.57B | |
| -1.19% | -2.68% | -17.02% | +432.55% | 26.6B | |
| -0.76% | -11.30% | +0.54% | -16.91% | 25.52B | |
| -6.09% | -11.19% | +224.80% | +351.08% | 18.23B | |
| +1.18% | -2.23% | +30.87% | -19.04% | 19.69B | |
| -1.49% | -6.35% | +7.84% | +540.26% | 15.16B | |
| +1.25% | -1.74% | +49.91% | +145.10% | 13.54B | |
| Average | -0.34% | -2.76% | +40.02% | +237.36% | 28.69B | |
| Weighted average by Cap. | -0.12% | -2.49% | +42.46% | +164.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.93M 3.97M 3.41M 3.21M 5.5M 377M 5.54M 37.99M 14.78M 191M 14.89M 14.56M 633M | 41.77M 56.6M 48.73M 45.76M 78.47M 5.39B 79.03M 542M 211M 2.73B 213M 208M 9.04B |
| Net income | -691M -936M -806M -757M -1.3B -89.04B -1.31B -8.96B -3.49B -45.15B -3.51B -3.44B -149B | -730M -990M -852M -800M -1.37B -94.18B -1.38B -9.48B -3.69B -47.76B -3.72B -3.64B -158B |
| Net Debt | -467M -633M -545M -512M -878M -60.25B -884M -6.07B -2.36B -30.55B -2.38B -2.33B -101B | -199M -269M -232M -218M -373M -25.6B -376M -2.58B -1B -12.98B -1.01B -988M -42.99B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/09/26 | US$13.92 | +2.17% | 1,022,509 |
| 31/08/26 | US$13.62 | -0.80% | 5,425,208 |
| 28/08/26 | US$13.73 | -4.19% | 3,906,883 |
| 27/08/26 | US$14.33 | +0.70% | 4,838,165 |
| 26/08/26 | US$14.23 | +6.51% | 11,634,709 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SMMT Stock
Select your edition
All financial news and data tailored to specific country editions
